Genedrive (LON: GDR) and its local distribution partner have signed a memorandum of understanding with the Kingdom of Saudi Arabia ministry of health to introduce the Genedrive MT-RNR1 ID Kit. This is a pilot that could extend to a national deal. David Nugent, who increased his stake from 15.1% to 16%, has offered a loan of up to £1m on terms to be agreed. The share price rebounded 122% to 1.044p.
Conygar Investment Company (LON: CIC) is selling its 203-acre brownfield land at Rhosgoch in Anglesey to Rhosgoch Property, a subsidiary of Stena Lin. The net proceeds will be £18.3m, compared with a valuation of £2.5m. NAV was £63.8m (107.5p/share) at the end of March 2025, but since then there has been a £750,000 loss on the sale of a Virgin Active gym. Premier Miton trimmed its stake from 13.9% to 12.8%, while First Equity has cut its interest from 13.2% to 12.8%. The share price jumped 27.5% to 32.5p.
Caledonian Holdings (LON: CHP) has entered an agreement with Mousdale Investment and Nevis Investments which will each swap 250,000 AlbaCo shaes for 6.25 million Caledonian Holdings shares at 0.004p each. This will take Caledonian Holdings’ sake in new smaller company focused bank AlbaCo to 5.47%. The share price improved 27.3% to 0.0035p.
Idox (LON: IDOX) is recommending a 71.5p/share cash bid from Long Path Opportunities Fund. This values the public sector software and services company at £339.5m. Long Path has been a long-term shareholder, and it owns 12% of Idox. The belief is that as a private company Idox will be able to take a longer-term view and invest in new technology with the backing of Long Path. The share price rose 27% to 70.6p.
FALLERS
Shareholders did not agree to the proposed fundraising by Anglesey Mining (LON: AYM) and management is preserving cash as it seeks alternative forms of financing. Without that the company will go into administration. Alumni Capital had agreed to offer equity funding of up to £2m. The share price slumped 97.2% to 0.25p.
Cancer treatments developer ValiRx (LON: VAL) is raising £750,000 at 0.25p/share and a WRAP offer could raise up to £300,000 more. The offer closes on 3 November. All subscribers get one warrant exercisable at 0.5p each with every new share. The cash will fund R&D, including the preclinical development of potential breast cancer treatment Cytolytix. The share price dipped 56.5% to 0.25p.
Great Western Mining Corporation (LON: GWMO) says soil sampling at the Huntoon copper project in Nevada shows elevated levels of tungsten, copper and zinc. The soil geochemical anomaly has been extended to more than 2.8km. The consistency of anomalies suggests a larger than anticipated mineralised system. Further analysis will help to design a new drilling campaign. The share price declined 28.2% to 1.4p.
Versarien (LON: VRS) has signed heads of terms with a UK quoted company for the sale of Total Carbide and the other remaining assets for £100,000 in cash and £100,000 in shares. The buyer will also take responsibility for £5.7m of loans plus interest. Versarien can operate with the support of creditors until the end of November. If the transaction goes ahead Versarien will become a shell. The share price fell 27% to 0.01p.